These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

175 related items for PubMed ID: 9021894

  • 21. Dopamine receptors and the dopamine hypothesis of schizophrenia.
    Seeman P.
    Synapse; 1987; 1(2):133-52. PubMed ID: 2905529
    [Abstract] [Full Text] [Related]

  • 22. Effect of desipramine during infancy and preweanling on dorsal striatal dopamine D1 and D2 receptor binding in adolescence in the rat.
    Hilakivi I, Rinne J, Marjamäki P.
    Pol J Pharmacol; 1999; 51(4):311-6. PubMed ID: 10540962
    [Abstract] [Full Text] [Related]

  • 23. Link between D1 and D2 dopamine receptors is reduced in schizophrenia and Huntington diseased brain.
    Seeman P, Niznik HB, Guan HC, Booth G, Ulpian C.
    Proc Natl Acad Sci U S A; 1989 Dec; 86(24):10156-60. PubMed ID: 2574862
    [Abstract] [Full Text] [Related]

  • 24. Dopamine receptor regulation of Ca2+ levels in individual isolated nerve terminals from rat striatum: comparison of presynaptic D1-like and D2-like receptors.
    Wu J, Dougherty JJ, Nichols RA.
    J Neurochem; 2006 Jul; 98(2):481-94. PubMed ID: 16805841
    [Abstract] [Full Text] [Related]

  • 25. Dopamine D2 receptor-mediated G protein activation assessed by agonist-stimulated [35S]guanosine 5'-O-(gamma-thiotriphosphate) binding in rat striatal membranes.
    Odagaki Y, Toyoshima R.
    Prog Neuropsychopharmacol Biol Psychiatry; 2006 Sep 30; 30(7):1304-12. PubMed ID: 16824659
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. [3H]Pramipexole: a selective radioligand for the high affinity dopamine D2 receptor in bovine striatal membranes.
    Ohnmacht U, Tränkle C, Mohr K, Gmeiner P.
    Pharmazie; 1999 Apr 30; 54(4):294-7. PubMed ID: 10234741
    [Abstract] [Full Text] [Related]

  • 31. [35S]Guanosine-5'-O-(3-thio)triphosphate binding as a measure of efficacy at human recombinant dopamine D4.4 receptors: actions of antiparkinsonian and antipsychotic agents.
    Newman-Tancredi A, Audinot V, Chaput C, Verrièle L, Millan MJ.
    J Pharmacol Exp Ther; 1997 Jul 30; 282(1):181-91. PubMed ID: 9223553
    [Abstract] [Full Text] [Related]

  • 32. D2-like dopamine receptors modulate SKCa channel function in subthalamic nucleus neurons through inhibition of Cav2.2 channels.
    Ramanathan S, Tkatch T, Atherton JF, Wilson CJ, Bevan MD.
    J Neurophysiol; 2008 Feb 30; 99(2):442-59. PubMed ID: 18094105
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Neurotensin receptor binding levels in basal ganglia are not altered in Huntington's chorea or schizophrenia.
    Palacios JM, Chinaglia G, Rigo M, Ulrich J, Probst A.
    Synapse; 1991 Feb 30; 7(2):114-22. PubMed ID: 1672780
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. [Specific binding of 3H-domperidone--a selective ligand of D2-dopamine receptors--by the human caudate nucleus].
    Zlobina GP, Chekalina ND.
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1987 Feb 30; 87(7):1043-5. PubMed ID: 2960110
    [Abstract] [Full Text] [Related]

  • 38. Drug and transmitter receptors in human brain. Characterization and localization of serotonin, dopamine and adrenergic receptors.
    Maloteaux JM.
    Acta Neurol Belg; 1986 Feb 30; 86(2):61-129. PubMed ID: 2873704
    [Abstract] [Full Text] [Related]

  • 39. Schizophrenia: elevation of dopamine D4-like sites, using [3H]nemonapride and [125I]epidepride.
    Seeman P, Guan HC, Van Tol HH.
    Eur J Pharmacol; 1995 Nov 14; 286(2):R3-5. PubMed ID: 8605946
    [Abstract] [Full Text] [Related]

  • 40. Comparison of phosphodiesterase 10A, dopamine receptors D1 and D2 and dopamine transporter ligand binding in the striatum of the R6/2 and BACHD mouse models of Huntington's disease.
    Miller S, Hill Della Puppa G, Reidling J, Marcora E, Thompson LM, Treanor J.
    J Huntingtons Dis; 2014 Nov 14; 3(4):333-41. PubMed ID: 25575954
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.